title: Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
authors.forename: Keiko A
authors.initials: KA
authors.lastname: Prospero-Garcia
authors.forename: Antonio
authors.initials: A
authors.lastname: Torres-Ruiz
authors.forename: Jesus
authors.initials: J
authors.lastname: Ramirez-Bermudez
authors.forename: Javier
authors.initials: J
authors.lastname: Velazquez-Moctezuma
authors.forename: Yoaly
authors.initials: Y
authors.lastname: Arana-Lechuga
authors.forename: Guadalupe
authors.initials: G
authors.lastname: Teran-Perez
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D000078785:Mirtazapine; D012148:Restless Legs Syndrome / Q000139:chemically induced*; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications
chemical_list: D000928:Antidepressive Agents; D005473:Fluoxetine; D008803:Mianserin; D000078785:Mirtazapine